279.17

0.16% -0.23

Labcorp Holdings Inc (LH)

Overview News Price History Option Chain Financials Why LH Down? Discussions Forecast Stock Split Dividend History

Labcorp Holdings Inc stock is traded at $279.17, with a volume of 435.68K. It is down -0.16% in the last 24 hours and up +9.63% over the past month. Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

Previous Close:

$279.40

Open:

$280.27

24h Volume:

435.68K

Relative Volume:

0.67

Market Cap:

$22.87B

Revenue:

$14.14B

Net Income/Loss:

$942.70M

P/E Ratio:

24.74

EPS:

11.2856

Net Cash Flow:

$1.38B

1W Performance:

+2.56%

1M Performance:

+9.63%

6M Performance:

+3.32%

1Y Performance:

+10.66%

1-Day Range:

$277.61

$281.56

1-Week Range:

$268.44

$290.65

52-Week Range:

$244.52

$293.72

Labcorp Holdings Inc Stock (LH) Company Profile

Name

Labcorp Holdings Inc

Sector

Healthcare (1083)

Industry

Diagnostics & Research (50)

Phone

(336) 229-1127

Address

358 S MAIN ST, BURLINGTON, NC

Employee

71,000

Twitter

@labcorp

Next Earnings Date

2026-07-30

Latest SEC Filings

LH's Discussions on Twitter

Compare LH vs TMO, DHR, IDXX, NTRA, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LH Labcorp Holdings Inc	278.96	22.91B	14.14B	942.70M	1.38B	11.29
TMO Thermo Fisher Scientific Inc	524.66	194.53B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	179.62	125.84B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	544.23	43.58B	4.45B	1.10B	1.06B	13.59
NTRA Natera Inc	263.17	38.26B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	133.47	37.52B	7.23B	1.41B	1.09B	4.979

Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-10-25	Downgrade	HSBC Securities	Buy → Hold
Apr-02-25	Initiated	Redburn Atlantic	Buy
Mar-04-25	Upgrade	Citigroup	Neutral → Buy
Jan-07-25	Upgrade	Evercore ISI	In-line → Outperform
Dec-10-24	Resumed	Jefferies	Buy
Oct-30-24	Upgrade	HSBC Securities	Hold → Buy
Oct-01-24	Initiated	Piper Sandler	Neutral
Mar-25-24	Upgrade	Argus	Hold → Buy
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-09-24	Initiated	Evercore ISI	In-line
Jan-03-24	Initiated	Barclays	Equal Weight
Sep-06-23	Initiated	HSBC Securities	Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Sep-19-22	Downgrade	Argus	Buy → Hold
Aug-22-22	Resumed	Morgan Stanley	Overweight
Jan-28-22	Downgrade	Deutsche Bank	Buy → Hold
Jan-11-21	Upgrade	Argus	Hold → Buy
Jan-11-21	Downgrade	Wolfe Research	Peer Perform → Underperform
Jan-08-21	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-14-20	Upgrade	BofA Securities	Neutral → Buy
Jul-13-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-02-20	Resumed	Deutsche Bank	Buy
May-15-20	Upgrade	Mizuho	Neutral → Buy
Apr-29-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-27-20	Upgrade	Citigroup	Neutral → Buy
Apr-27-20	Upgrade	Wolfe Research	Underperform → Peer Perform
Jan-08-20	Initiated	Wells Fargo	Overweight
Jul-16-19	Upgrade	BofA/Merrill	Underperform → Neutral
Jun-21-19	Upgrade	Deutsche Bank	Hold → Buy
Apr-02-19	Upgrade	Jefferies	Hold → Buy
Jan-17-19	Initiated	UBS	Buy
Jan-03-19	Downgrade	BofA/Merrill	Neutral → Underperform
Dec-03-18	Downgrade	Craig Hallum	Buy → Hold
Oct-30-18	Downgrade	Argus	Buy → Hold
Oct-25-18	Downgrade	Canaccord Genuity	Buy → Hold
Oct-19-18	Resumed	BofA/Merrill	Buy
Jun-07-18	Upgrade	KeyBanc Capital Mkts	Sector Weight → Overweight
May-01-18	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-23-18	Initiated	Argus	Buy

View All

Labcorp Holdings Inc Stock (LH) Latest News

01:52 AM